ReviewCureus2022
Correlation of Morphological Findings of Endometrium With Concerned Hormone Levels in Patients With Abnormal Uterine Bleeding: A Narrative Review.
Review in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 4 citations in OpenAlex.
- Effect of norethisterone dose and duration in the management of abnormal uterine bleeding: a narrative review and case report.Drugs in context · 2024Review
- Parsing the Q-Markers of Baoyin Jian to Treat Abnormal Uterine Bleeding by High-Throughput Chinmedomics Strategy.Pharmaceuticals (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Abnormal uterine bleeding (AUB) is a distressing menstrual condition that continues to be one of the most common rationales for hysterectomy in underdeveloped countries. It can be either focal (breakthrough bleeding) or diffuse (bleeding throughout the body) (withdrawal bleeding). AUB has a negative impact on a female's physical, social, and emotional well-being. It is caused by chronic endometritis, micro erosions, or vascular fragility caused by micro-vessel structural anomalies. Polyps, submucosal leiomyoma, atrophy, and cancer can all produce endometritis and micro erosions in otherwise healthy endometrium (organic causes). In hyperplasia and endometrial cancers, especially type I, estrogen and progesterone hormones are also expressed. The level of these hormones gives prognostic information. They also provide amenability to hormonal therapy. Hormonal imbalance is the main component involved in the pathogenesis of dysfunctional uterine bleeding (DUB).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.